Literature DB >> 7769307

HEp-2 cell-adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea.

J J Mathewson1, Z D Jiang, A Zumla, C Chintu, N Luo, S R Calamari, R M Genta, A Steephen, P Schwartz, H L DuPont.   

Abstract

Diarrhea occurs commonly in African human immunodeficiency virus (HIV) infections. A case-control (HIV-positive vs. -negative) study of adults with diarrhea was done in Lusaka, Zambia, to determine the prevalence of intestinal infection by HEp-2 cell-adherent Escherichia coli. Adherent E. coli were more common in HIV-positive patients with acute diarrhea than among HIV-negative controls (60% vs. 33%) and were found significantly more often in HIV-positive patients with chronic diarrhea than among HIV-negative controls with chronic diarrhea (79% vs. 17%, P < .002). Adherent strains were found significantly more often among HIV-positive patients (69%) than in 22 asymptomatic subjects (36%, P < .02). The HEp-2 cell adherence of the E. coli strains did not show a common pattern. Adherent bacteria were also observed in colonic biopsies from 32% of Zambians with chronic diarrhea who underwent endoscopy. Adherent E. coli may be an important cause of HIV-associated diarrhea in Zambia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769307     DOI: 10.1093/infdis/171.6.1636

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea.

Authors:  M Sutjita; A R Bouckenooghe; J A Adachi; Z D Jiang; J J Mathewson; C D Ericsson; H L DuPont
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 2.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

3.  Enteroaggregative Escherichia coli: An Emerging Pathogen.

Authors:  David B. Huang; Hoonmo Koo; Herbert L. DuPont
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

4.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

5.  HEp-2 cell adherence patterns, serotyping, and DNA analysis of Escherichia coli isolates from eight patients with AIDS and chronic diarrhea.

Authors:  Y Polotsky; J P Nataro; D Kotler; T J Barrett; J M Orenstein
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya.

Authors:  C Mwachari; B I Batchelor; J Paul; P G Waiyaki; C F Gilks
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

7.  HEp-2 cell-adherent Escherichia coli and intestinal secretory immune response to human immunodeficiency virus (HIV) in outpatients with HIV-associated diarrhea.

Authors:  J J Mathewson; B M Salameh; H L DuPont; Z D Jiang; A C Nelson; R Arduino; M A Smith; N Masozera
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

8.  Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells.

Authors:  Mohamad S Miqdady; Zhi-Dong Jiang; James P Nataro; Herbert L DuPont
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Identification of an aggregative adhesion fimbria (AAF) type III-encoding operon in enteroaggregative Escherichia coli as a sensitive probe for detecting the AAF-encoding operon family.

Authors:  Christine Bernier; Pierre Gounon; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Enteroaggregative coli: A Pathogen Bridging the North and South.

Authors:  Teresa Estrada-Garcia; Iza Perez-Martinez; Rodolfo Bernal-Reynaga; Mussaret B Zaidi
Journal:  Curr Trop Med Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.